Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong-Rong Lai

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 17, 2019
[Clinical and Bacteriological Analysis of Bacterial Bloodstream Infections in Patients with Acute Leukemial]Jie-Min Wei, Xiao-Xuan Lai, Zhong-Ming Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 13, 2011
[A 3-year clinical trial of deferasirox in heavily iron-overloaded patients with Beta-thalassemia major]Rong-Rong Liu, Jie Ma, Xin-Hua Zhang, et al.
American Journal of Hematology|October 28, 2014
Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamineDudley J Pennell, John B Porter, Antonio Piga, et al.
European Journal of Haematology|September 18, 2014
Favorable prognosis of biallelic CEBPA gene mutations in acute myeloid leukemia patients: a meta-analysisHong-Ying Li, Dong-Hong Deng, Ying Huang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 6, 2022
[Clinical Analysis of Bloodstream Infection after Hematopoietic Stem Cell Transplantation]Ying-Ying Wu, Bei-Cai Liu, Lian-Jin Liu, et al.
Blood Cells, Molecules & Diseases|February 9, 2016
Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS studyAli T Taher, M Domenica Cappellini, Yesim Aydinok, et al.
Journal of Hematology & Oncology|August 21, 2014
Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG)Yong-Rong Lai, Yu-Hong Chen, Deng-Ming Hu, et al.
Blood Reviews|March 24, 2023
Thalassaemia in ChinaWei-da Wang, Fang Hu, Dun-Hua Zhou, et al.
Chinese Medical Journal|July 16, 2019
Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myelomaYao Chen, Wei-Jun Fu, Lan-Ping Xu, et al.
Journal of Hematology & Oncology|September 16, 2021
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 updateXiao-Hui Zhang, Jing Chen, Ming-Zhe Han, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 17, 2019
[Clinical and Bacteriological Analysis of Bacterial Bloodstream Infections in Patients with Acute Leukemial]Jie-Min Wei, Xiao-Xuan Lai, Zhong-Ming Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 13, 2011
[A 3-year clinical trial of deferasirox in heavily iron-overloaded patients with Beta-thalassemia major]Rong-Rong Liu, Jie Ma, Xin-Hua Zhang, et al.
American Journal of Hematology|October 28, 2014
Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamineDudley J Pennell, John B Porter, Antonio Piga, et al.
European Journal of Haematology|September 18, 2014
Favorable prognosis of biallelic CEBPA gene mutations in acute myeloid leukemia patients: a meta-analysisHong-Ying Li, Dong-Hong Deng, Ying Huang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 6, 2022
[Clinical Analysis of Bloodstream Infection after Hematopoietic Stem Cell Transplantation]Ying-Ying Wu, Bei-Cai Liu, Lian-Jin Liu, et al.
Blood Cells, Molecules & Diseases|February 9, 2016
Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS studyAli T Taher, M Domenica Cappellini, Yesim Aydinok, et al.
Journal of Hematology & Oncology|August 21, 2014
Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG)Yong-Rong Lai, Yu-Hong Chen, Deng-Ming Hu, et al.
Blood Reviews|March 24, 2023
Thalassaemia in ChinaWei-da Wang, Fang Hu, Dun-Hua Zhou, et al.
Chinese Medical Journal|July 16, 2019
Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myelomaYao Chen, Wei-Jun Fu, Lan-Ping Xu, et al.
Journal of Hematology & Oncology|September 16, 2021
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 updateXiao-Hui Zhang, Jing Chen, Ming-Zhe Han, et al.
Pageof 4